October 28 from 5:30 pm – 7:30 pm CDT
Horizon E/F Ballroom, Marriott Marquis | Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Program Description
Please join expert rheumatologist Dr. Christopher Mecoli, Associate Professor of Medicine at Johns Hopkins School of Medicine, and expert pulmonologist Dr. Zulma Yunt, Associate Professor at National Jewish Health, as they team up to highlight the role of collaborative care in the diagnosis and management of patients with autoimmune associated interstitial lung disease (ILD). Attendees will have the opportunity to test their knowledge in real time through an interactive presentation of sample patient cases. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology. This is a non-CME event and does not qualify for CME, CE, or MOC credit. This presentation is open to all ACR Convergence 2025 attendees. Onsite registration will occur for conference registrants only at the program entrance on a first-come, first-served basis. This presentation is sponsored by and made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
(08/25) EM-US-104005